Biostats: Screening Flashcards

1
Q

What are the Levels of Prevention?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the difference between diagnostic and screening tests?

A
  1. Diagnostic tests are used for persons in whom disease is suspected, due to symptoms, physical findings, or laboratory findings.
  2. Screening tests are used to identify early signs of a disease in people with no signs or symptoms of the disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is sensitivity?

A

probability the test will be positive in someone with the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Specificity?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is predictive value positive? PVP

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is predictive value negative? PVN

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does prevalence affect sensitivity, specificity, PVP, PVN?

A

Sensitivity and specificity are independent. As prevalence increases, PVP will increase, and PVN decreases slightly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are post test probabilities?

A

POSTTEST (POSTERIOR) PROBABILITY
= the probability of the disease after a test result.

a. After a positive test result:
Posterior Probability of a Positive Test
= a/(a+b) = PVP

b. After a negative test result:
Posterior Probability of a Negative Test
= c/(c+d) = 1 - PVN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is lead time and length bias?

A

a. Lead time bias = the tendency for screen-detected cases to APPEAR to live longer than clinically-detected cases because “lead time” has been added to their duration.

“Lead time” is the time by which a screening test advances the date of diagnosis from the usual symptomatic phase to an earlier pre-symptomatic phase.

b. Length bias (or length biased sampling) - The tendency for screen-detected cases to live longer than clinically-detected cases because they invariably include an over-representation of cases with slowly progressing disease.

Whenever cases vary in the lengths of their detectable preclinical phases, then a screening test will always detect a disproportionate number of cases of slowly progressing disease and miss rapidly progressing cases that are in a detectable preclinical phase only briefly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly